BioGaia AB (BGLAF)
BioGaia Market Cap : 1.193B for May 15, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| BONESUPPORT HOLDING AB | 1.656B |
| BioInvent International AB | 216.40M |
| Hansa Biopharma AB | 289.23M |
| BioArctic AB | 3.075B |
| Swedish Orphan Biovitrum AB | 16.19B |
Market Cap Related Metrics
| PE Ratio | 33.89 |
| PS Ratio | 7.283 |
| PEG Ratio | 1.591 |
| Price to Book Value | 8.102 |
| Price to Free Cash Flow | 32.69 |
| Price | 11.79 |
| Earnings Yield | 2.95% |
| PEGY Ratio | 1.357 |
| Operating PE Ratio | 26.43 |
| Normalized PE Ratio | 33.88 |